Literature DB >> 47251

Effects of testosterone and erythropoietin on erythroid colony formation in human bone marrow cultures.

Y Moriyama, J W Fisher.   

Abstract

The effects of testosterone and erythropoietin (ESF) on erythroid colony formation in normal human bone marrow cultures were studied in vitro using a methyl cellulose gel system. Testosterone was found to produce a significant increase in erythroid colony formation at concentrations of 10-4-10-4M in vitro. In this system, the numbers of erythroid colonies formed per plate increased in direct proportion to the increase in the number of erythroid precursors inoculated as well as to the increase in the dose of ESF in vitro. In addition, a synergistic effect of a combination of testosterone and ESF on erythroid colony formation was seen when ESF was present at high concentrations. These data suggest that a greater number of erythropoietin-responsive cells are available for ESF to differentiate into the nucleated erythroid cell line in the presence of testosterone, indicating that the effect of a combination of testosterone and ESF is greater in enhancing erythropoiesis than the additive effects of either agent alone.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 47251

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  18 in total

1.  Isolation and transcriptome analyses of human erythroid progenitors: BFU-E and CFU-E.

Authors:  Jie Li; John Hale; Pooja Bhagia; Fumin Xue; Lixiang Chen; Julie Jaffray; Hongxia Yan; Joseph Lane; Patrick G Gallagher; Narla Mohandas; Jing Liu; Xiuli An
Journal:  Blood       Date:  2014-10-22       Impact factor: 22.113

Review 2.  Androgen therapy for anemia in elderly uremic patients.

Authors:  J F Navarro; C Mora
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

3.  Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point.

Authors:  Eric Bachman; Thomas G Travison; Shehzad Basaria; Maithili N Davda; Wen Guo; Michelle Li; John Connor Westfall; Harold Bae; Victor Gordeuk; Shalender Bhasin
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-10-24       Impact factor: 6.053

4.  Mechanisms responsible for reduced erythropoiesis during androgen deprivation therapy in men with prostate cancer.

Authors:  Thiago Gagliano-Jucá; Karol M Pencina; Tomas Ganz; Thomas G Travison; Philip W Kantoff; Paul L Nguyen; Mary-Ellen Taplin; Adam S Kibel; Zhuoying Li; Grace Huang; Robert R Edwards; Elizabeta Nemeth; Shehzad Basaria
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-10-16       Impact factor: 4.310

Review 5.  Hematological changes during androgen deprivation therapy.

Authors:  Mathis Grossmann; Jeffrey D Zajac
Journal:  Asian J Androl       Date:  2012-01-09       Impact factor: 3.285

Review 6.  Iron considerations for the athlete: a narrative review.

Authors:  Marc Sim; Laura A Garvican-Lewis; Gregory R Cox; Andrew Govus; Alannah K A McKay; Trent Stellingwerff; Peter Peeling
Journal:  Eur J Appl Physiol       Date:  2019-05-04       Impact factor: 3.078

Review 7.  Androgens and erythropoiesis: past and present.

Authors:  S Shahani; M Braga-Basaria; M Maggio; S Basaria
Journal:  J Endocrinol Invest       Date:  2009-04-07       Impact factor: 4.256

8.  Testosterone administration inhibits hepcidin transcription and is associated with increased iron incorporation into red blood cells.

Authors:  Wen Guo; Eric Bachman; Michelle Li; Cindy N Roy; Jerzy Blusztajn; Siu Wong; Stephen Y Chan; Carlo Serra; Ravi Jasuja; Thomas G Travison; Martina U Muckenthaler; Elizabeta Nemeth; Shalender Bhasin
Journal:  Aging Cell       Date:  2013-02-28       Impact factor: 9.304

9.  Erythroid colony formation from human fetal liver.

Authors:  P T Rowley; B M Ohlsson-Wilhelm; B A Farley
Journal:  Proc Natl Acad Sci U S A       Date:  1978-02       Impact factor: 11.205

10.  In vitro CFU-E and BFU-E responses to androgen in bone marrow from children with primary hypoproliferative anaemia: a possible therapeutic assay.

Authors:  M Claustres; G Margueritte; C Sultan
Journal:  Eur J Pediatr       Date:  1986-02       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.